Creative Planning’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
VPM
VCM
NAMI
CC
Creative Planning's LGND Position: Q1 2026 in Review
Creative Planning increased its Ligand Pharmaceuticals (LGND) stake by 19% in Q1 2026, buying an estimated $269K and bringing the position to 8,505 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2035.
Creative Planning first reported a position in LGND in Q2 2013 and has held it in 34 quarters since. The position peaked at $3.13M in Q3 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Creative Planning held 8,505 shares of Ligand Pharmaceuticals worth $1.7M as of Q1 2026.
- Creative Planning bought 1,360 Ligand Pharmaceuticals shares in Q1 2026, an estimated $269K.
- Ligand Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2035 holding.
- Creative Planning first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 34 quarters since.
- Creative Planning's Ligand Pharmaceuticals position peaked at $3.13M in Q3 2018.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.